تثبيت وحدة حرية التحويل!
تثبيت وحدة حرية التحويل!
تثبيت وحدة حرية التحويل!
|
تثبيت وحدة حرية التحويل!
- Amgen | A Worldwide Pioneer in Biotechnology
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines, helping make people’s lives easier, fuller and longer
- Amgen - Wikipedia
Amgen Inc is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California The company is ranked 18th on the list of largest biomedical companies by revenue
- Amgen Inc. (AMGN) Stock Price, News, Quote History - Yahoo Finance
Find the latest Amgen Inc (AMGN) stock quote, history, news and other vital information to help you with your stock trading and investing
- AMGN | Amgen Inc. Stock Overview (U. S. : Nasdaq) | Barrons
Complete Amgen Inc stock information by Barron's View real-time AMGN stock price and news, along with industry-best analysis
- 20 people in Japan died after taking Amgen drug - MSN
Twenty people in Japan who took Amgen’s rare-disease drug Tavneos have died, and at least 22 developed a potentially fatal liver injury, according to Kissei Pharmaceutical, which sells the
- What’s at stake in Amgen’s showdown with the FDA?
The agency accused Amgen of manipulating data for its fast-growing drug Tavneos and wants it pulled from the market, but the large pharma is digging its heels in
- Amgen (AMGN) Stock Price, News Analysis - MarketBeat
Amgen Inc (NASDAQ: AMGN) is a global biotechnology company founded in 1980 and headquartered in Thousand Oaks, California The company focuses on discovering, developing, manufacturing and delivering human therapeutics that address serious illnesses
- About | Amgen Europe
A biotechnology innovator since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential
|
|
|